Salus Research   Report issue

For profit Phase 2 Phase 4
Founded: Fort Wayne IN United States (2011)

Organization Overview

First Clinical Trial
2017
NCT02864901
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Salus Research | Salus Research, Inc | Salus Research, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

ethanol (4 trials)

Eucalyptol (listerine) (3 trials)

Drugs in Phase 2 Trials (1)

ksl-2 (1 trial)

Drugs in Other Trials (2)

streptococcus salivarius (1 trial)

tin difluoride (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 5